Correlation of fixed aqueous layer thickness around peg-modified liposomes with in vivo efficacy of antitumor agent-containing liposomes

Current Drug Discovery Technologies

Volumn 8, Issue 4, 2011, Pages 357-366

  Sugiyama, Ikumi ^a   Sadzuka, Yasuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Biological factor; FALT; Liposome; Physical character; Polyethyleneglycol

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; LIPOSOME; MACROGOL;

ARTICLE; DRUG EFFICACY; ELECTRIC POTENTIAL; IN VIVO STUDY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD PROTEINS; DOXORUBICIN; DRUG CARRIERS; DRUG DESIGN; HUMANS; LIPOSOMES; MICE; MONONUCLEAR PHAGOCYTE SYSTEM; NEOPLASMS, EXPERIMENTAL; POLYETHYLENE GLYCOLS; TIME FACTORS;

EID: 82155166671     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016311798109344     Document Type: Article

References (49)

1. Gabizon A, Gore D, Barenholz Y. Investigations on the antitumor efficacy of liposome-associated doxorubicin in murine tumor mod- els. Isr Med Sci 1988; 24: 512-7. (Pubitemid 19052762)
2. Goren D, Gabizon A, Barenholz Y. The influence of physical char- acteristics of liposomes containing doxorubicin on their pharma- cological behavior. Biochim Biophys Acta 1990; 1029: 285-94. (Pubitemid 20372065)
3. Patel HM. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug Carrier Syst 1992; 9: 39-90.
4. Devine DV, Marja MJ. The role of immunoproteins in the survival of liposomes in the circulation. Crit Rev Ther Drug Carrier Syst 1997; 14: 105-31. (Pubitemid 27169244)
5. Berestein GL, Kasi L, Rosemblum MG, et al. Distribution and pharmacology of intravenous technetium-99-m-labeled multilamellar liposomes in rats and mice. Cancer Res 1984; 44: 375-8.
6. Sadzuka Y, Nakai S, Miyagishima A, Nozawa Y, Hirota S. The effect of dose on the distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes. J Drug Targeting 1995; 3: 31-7.
7. Needham D, McIntosh TJ, Lasic DD. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim Biophys Acta 1992; 1108: 40-8.
8. Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Activity of amphipathic poly(ethyleneglycol)5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to taeget. Biochim Biophys Acta 1991; 1062: 142-8.
9. Yuda T, Pongpaibul Y, Maruyama K, Iwatsuru M. Activity of amphipathic polyethyleneglycols to prolong the circulation time of liposomes. J Pharm Sci Technol Jpn 1999; 59: 32-42.
10. Tilcock C, Cullis P, Dempsey T, Youens BN, Fisher D. Aqueous two-phase polymer partitioning of lipid vesicles of defined siza and composition. Biochim Biophys Acta 1989; 979: 208-14. (Pubitemid 19059925)
11. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1991; 1062: 77-82.
12. Kuhl TL, Leckband DE, Lasic DD, Israelachvili JN. Midulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophs J 1994; 66: 1479-88. (Pubitemid 24145145)
13. Torchilin VP, Omelyanenko VG, Papisov MI, et al. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer- coated liposome longevity. Biochem Biophys Acta 1994; 1195: 11-20.
14. Janzen J, Song X, Brooks DE. Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis. Biophys J 1996; 70: 313-20.
15. Coukell AJ, Spencer CM. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Drugs 1997; 53: 520-38. (Pubitemid 27117367)
16. Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet 2003; 42: 419-36. (Pubitemid 36649037)
17. Boswell GW, Buell D, Bekersky I. AmBisome (liposomal ampho- tericin B): a comparative review. J Clin Pharmacol 1998; 38: 538-92.
18. Moghimi SM, Patel HM. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett 1988; 233: 143-7.
19. Moghimi SM, Patel HM. Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Biochim Biophys Acta 1989; 984: 384-7. (Pubitemid 19222130)
20. Senior JH. Fate and behavior of liposomes in vivo: A review of controlling factors. CRC Crit Rev Ther Drug Carrier Systems 1987; 3: 123-93. (Pubitemid 17219201)
21. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethylene glycols effectively prolong the circulation times of liposomes. FEBS Lett 1990; 268: 235-7. (Pubitemid 20233874)
22. Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochem Biophys Acta 1990; 1029: 91-7. (Pubitemid 20346426)
23. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochem Biophys Acta 1991; 1066: 29-36.
24. Lasic D, Martin R, Gabizon A, Huang S, Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular ori- gin of the extended circulation times. Biochim Biophys Acta 1991; 1070: 187-92.
25. Shimada K, Miyagishima A, Sadzuka Y, et al. Determination of the thickness of the fixed aqueous layer around the polyethyleneglycol- corted liposomes. J Drug Target 1995; 3: 283-9. (Pubitemid 26032031)
26. Zeisig R, Shimada K, Hirota S, Arndt D. Effect of sterical stabiliza- tion on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Biochim Biophys Acta 1996; 1285: 237-45. (Pubitemid 26403082)
27. Gregoriadis G. Liposomes as Drug Carriers: Recent Trends and Progress. John Wiley and Sons: Chichester 1988.
28. Hwang KJ. In: Liposomes; Biophysics to Therapeutics; Marcel Dekker: New York 1987; pp. 109-156.
29. Maruyama K, Kennel SJ, Huang L. Lipid composition is important for highly efficient target binding and retentionof immu- noliposomes. Proc Natl Acad Sci; 1990; USA; pp. 5744-8.
30. Allen TM, Chonn A. Large unilamellar lipospmes with low uptake into the reticuloendothelial system. FEBS Lett 1987; 223: 42-6.
31. Allen TM, Hansen C, Rutledge J. Liposomes with prolonged circu-lation times: Factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta 1989; 981: 27-35. (Pubitemid 19127766)
32. Allen TM. In: Liposomes in the Therapy of Infectious Diseases and Cancer. UCLA symposium on Molecular and Cellular Biology; 1989; Alan R. Liss. New York; pp. 405-15.
33. Woodle MC, Collons LR, Sponsier E, Kossovsky N, Papahad-jopoulos D, Martin FJ. Sterically stabilized liposomes: Reduction in electrophoretic mobility but not electrostatic surface potential. Biophys J 1992; 61: 902-10.
34. Verwey EJW, Overbeek JThG. Theory of the stability of lyophobic colloids; 1949; Elsevier. Amsterdam; pp. 164-85.
35. Israelachivili JN. In: Intermolecular and Surface Forces; 1985; Academic Press. London; pp. 223-252.
36. Kondo T, Ohshima H, Muramatsu N, Makino K. Biophysical Chemistry; 1992; Sankyoshuppan. Tokyo: chapter 4-5.
37. Sadzuka Y, Nakade A, Hirama R, et al. Effects of mixed polyeth-yleneglycol modification on fixed aqueous layer thickness and anti-tumor activity of doxorubicin containing liposome. Int J Pharm 2002; 238: 171-80. (Pubitemid 34457886)
38. Needham D, Stoicheva N, Zhelev DV. Exchange of monooleoyl- phosphatidylcholine as monomer and micelle with membranes con-taining poly(ethylene glycol)-lipid. Biophys J 1997; 73: 2615-29. (Pubitemid 27471471)
39. Kenworrthy AK, Hristova K, Needham D, McIntosh TJ. Range and magnitude of the steric pressure between bilayers containing phos-pholipids with covalently attached poly(ethylene glycol). Biophys J 1995; 68: 1921-36.
40. Maruyama K, Yuda T, Okamoto A, Ishikura C, Kojima S, Iwatsuru M. Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. Chem Pharm Bull 1991; 39: 1620-2.
41. Sadzuka Y, Nakade A, Tsuruda T, Sonobe T. Study on the charac-terization of mixed polyethyleneglycol modified liposomes con-taining doxorubicin. J Control Release 2003; 91: 271-80. (Pubitemid 36976760)
42. Wu NZ, Da D, Rudoll TL, Needham D, Whorton AR, Dewhist W. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 1993; 53: 3765-70. (Pubitemid 23252040)
43. Schmitz S, Allen TM, Jimbow K. Polyethylene-glycol-mediated delivery of liposome-entrapped pigment into fibroblasts: experi-mental pigment cells as models for mutator phenotypes. Cancer Res 1992; 52: 6638-45.
44. Papafadjopoulos D, Allen TM, Gabizon A, et al. Sterically stabi-lized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991; 88(24): 11460-4. (Pubitemid 21916061)
45. Carrion C, Domingo JC, de Madariaga MA. Preparation of long circulation immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. Chem Phys Lipids 2001; 113: 97-110. (Pubitemid 33001479)
46. Beugin-Deroo S, Ollivon M, Lesieur S. Bilayer stability and im-permeability of nanonic surfactant vesicles sterically stabilized by PEG-cholesterol conjugates. J Colloid Interf Sci 1998; 202: 324-33. (Pubitemid 28394212)
47. Sugiyama I, Sonobe T, Sadzuka Y. Effect of hybridized liposome by novel modification with some polyethyleneglycol-lipids. Int J Pharm 2009; 372: 177-83.
48. Sugiyama I, Sadzuka Y. Characterization of novel mixed polyeth-yleneglycol modified liposomes. Biol Pharm Bull 2007; 30: 208-11. (Pubitemid 46066350)
49. Matsumura Y, Maeda H. A new concept for macromolecular thera-peutics in cancer chemotherapy: mechanism of tumoritropic accu-mulation of proteins and antitumor agent smancs. Cancer Res 1986; 46: 6387-92. (Pubitemid 17221789)